GO
Loading...

Gilead Sciences Inc

More

  • *Dollar dips but oversupply worry weighs on oil. NEW YORK, March 23- U.S. stocks were little changed on Monday on the heels of a rally in the prior week, as investors weighed fluctuations in the dollar and its impact on other markets, including crude prices. The Nasdaq was less than 0.5 percent of a closing record set on March 10, 2000.

  • Midday Glance: Biotechnology companies Monday, 23 Mar 2015 | 1:32 PM ET

    Amgen Inc. fell $3.35 or 2.0 percent, to $166.75. Biogen Idec fell $11.26 or 2.4 percent, to $464.72. Celgene Corp. fell $4.92 or 3.8 percent, to $123.58.

  • US STOCKS-Wall St little changed as energy pares gains Monday, 23 Mar 2015 | 12:29 PM ET

    *Dollar weakens, supporting crude prices. NEW YORK, March 23- U.S. stocks were little changed on Monday, following strong gains in major indexes the previous week, as investors assessed gyrations in the dollar and crude prices and their impact on equities. "The market has been in a back-and-forth motion for the last couple of weeks, caught between the potential for...

  • Early Glance: Biotechnology companies Monday, 23 Mar 2015 | 10:12 AM ET

    Amgen Inc. fell $3.94 or 2.3 percent, to $166.16. Biogen Idec fell $7.09 or 1.5 percent, to $468.89. Celgene Corp. fell $4.67 or 3.6 percent, to $123.83.

  • US STOCKS-Stocks up as dollar ads to losses, oil gains Monday, 23 Mar 2015 | 10:06 AM ET

    *U.S. dollar extends losses, crude turns positive. NEW YORK, March 23- U.S. stocks edged higher on Monday following strong gains in major indexes the previous week, as investors assessed gyrations in the dollar and crude prices and their impact on equities. "The market has been in a back-and-forth motion for the last couple of weeks, caught between the potential for...

  • *Brent, WTI prices fall again after Saudi comment on supply. NEW YORK, March 23- U.S. stocks were set to dip at the open on Monday following strong gains in major indexes the previous week, as investors assessed gyrations in the dollar and crude prices and their impact on equities. "The market has been in a back and forth motion for the last couple of weeks, caught between...

  • NEW YORK, March 23- U.S. stock index futures ticked lower on Monday following strong gains in major indexes last week, as investors eyed negotiations over the future of Greece in the euro zone and as oil prices fell further. *German Chancellor Angela Merkel and Greek Prime Minister Alexis Tsipras were set to meet in Berlin, and Tsipras' list of reform proposals will...

  • Traders kept tabs on a meeting in Europe between the leaders of Greece and Germany for signs of progress in Greece's debt negotiations. Greece faces a cash crunch in the coming weeks and is in talks with its European lenders on what steps it must take to receive more loans. Greece's Prime Minister, Alexis Tsipras, committed to keeping a dialogue open on reforms...

  • Final Glance: Biotechnology companies Friday, 20 Mar 2015 | 8:00 PM ET

    Amgen Inc. rose$. 99 or. 6 percent, to $170.10. Biogen Idec rose $42.33 or 9.8 percent, to $475.98. Celgene Corp. rose $3.17 or 2.5 percent, to $128.50.

  • Lightning Round: Too much competition in this Friday, 20 Mar 2015 | 7:44 PM ET
    Mad Money Lightning Round

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Cramer Remix: Cha-ching! Time to cash in Friday, 20 Mar 2015 | 7:26 PM ET
    Jim Cramer on the set of Mad Money

    “Mad Money” host Jim Cramer on why this rally won’t last forever and why you should take some off the table on this.

  • 6 trades on surging biotech sector Friday, 20 Mar 2015 | 6:39 PM ET

    Big-name biotech stocks have been on a tear, but some "Fast Money" traders warned the run may not continue.

  • These stocks are insulated from the rising dollar Friday, 20 Mar 2015 | 4:21 PM ET
    Biotech

    Biotechs and small caps are the top performers on Wall Street, with the health-care subsector up about 8 percent for the week.

  • Midday Glance: Biotechnology companies Friday, 20 Mar 2015 | 1:25 PM ET

    Amgen Inc. rose$. 39 or. 2 percent, to $169.50. Biogen Idec rose $38.60 or 8.9 percent, to $472.25. Celgene Corp. rose $1.36 or 1.1 percent, to $126.69.

  • Early Glance: Biotechnology companies Friday, 20 Mar 2015 | 10:19 AM ET

    Amgen Inc. rose $1.93 or 1.1 percent, to $171.04. Biogen Idec rose $29.86 or 6.9 percent, to $463.51. Celgene Corp. rose $1.29 or 1.0 percent, to $126.62.

  • Workers at 11 companies haul in $3.5M each! Friday, 20 Mar 2015 | 8:57 AM ET
    Workers enter an Exxon Mobil refinery

    Employees at 11 non-financial companies in the Standard & Poor's 500 brought in more revenue apiece than any other in America. USA TODAY reports.

  • Midday Glance: Biotechnology companies Thursday, 19 Mar 2015 | 2:00 PM ET

    Amgen Inc. rose $1.24 or. 7 percent, to $167.78. Biogen Idec rose $7.84 or 1.8 percent, to $435.77. Celgene Corp. rose $2.16 or 1.8 percent, to $124.84.

  • Early Glance: Biotechnology companies Thursday, 19 Mar 2015 | 10:22 AM ET

    Amgen Inc. rose $1.31 or. 8 percent, to $167.85. Biogen Idec rose $9.78 or 2.3 percent, to $437.71. Celgene Corp. rose $2.07 or 1.7 percent, to $124.75.

  • Charity attacks Gilead over hepatitis C drug restrictions Wednesday, 18 Mar 2015 | 4:17 PM ET

    March 18- Charity Medecins Sans Frontieres has accused U.S. drugmaker Gilead Sciences Inc of restricting access to its breakthrough hepatitis C drug Sovaldi in developing countries as it tries to protect profit margin in wealthier nations. "We're seeing Gilead trying everything it can to squeeze every last drop of profit out of some middle-income and...

  • Midday Glance: Biotechnology companies Wednesday, 18 Mar 2015 | 2:23 PM ET

    Amgen Inc. fell$. 43 or. 3 percent, to $162.64. Biogen Idec fell $6.08 or 1.4 percent, to $420.04. Celgene Corp. rose$. 07 or. 1 percent, to $121.10.